Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Growth 2026-2032
The global Continuous Glucose Monitoring (CGM) System for Diabetes Management market size is predicted to grow from US$ 14185 million in 2025 to US$ 30119 million in 2032; it is expected to grow at a CAGR of 11.4% from 2026 to 2032.
A continuous glucose monitoring system is a medical device and data-enabled care solution for diabetes management. It measures glucose levels continuously by placing a disposable sensor in the subcutaneous interstitial space, converting biochemical signals into time-series glucose readings, and presenting trends, rate-of-change insights, and alerts for high and low glucose events. A typical system includes a sensor, a signal transmission module, and a display endpoint such as a dedicated receiver or a mobile application, supported by analytics and reporting functions that facilitate therapy adjustment and follow-up care.
In terms of form factor, the mainstream product is a patch-worn wearable sensor. By usage mode, products commonly fall into real-time systems that automatically present readings and alerts and scan-based systems that require user-initiated checks, with a smaller segment of implantable long-wear options. The core value lies in transforming episodic point testing into continuous visibility of glucose dynamics, enabling earlier risk detection, more informed dosing and lifestyle decisions, and standardized metrics for long-term glycemic evaluation across diverse care settings.
In 2025, annual global shipments of continuous glucose monitoring (CGM) systems for diabetes management were estimated at approximately 1.6?2.4 million units. On an ex-factory basis (a practical proxy for FOB net selling value), the first-year ex-factory value per system typically ranged from around USD 900 to 1,400 per system.
Driven by the rising global diabetes burden and the shift toward more proactive glycemic control, continuous glucose monitoring systems are evolving from niche tools for highly engaged users into foundational infrastructure for broader chronic care. Continuous trend visibility and real-time risk alerts improve day-to-day decision making, increase patient engagement, and provide a scalable data backbone for clinical follow-up and remote care models. As wear comfort improves and wear duration extends, factory calibration and simplified onboarding are lowering adoption barriers. Market expansion is moving beyond type 1 diabetes into insulin-treated type 2 diabetes, and in certain markets further into wider type 2 populations where providers and payers recognize the value of preventing deterioration and acute events.
Challenges Risks and Demand Trends
Key uncertainties center on product reliability and manufacturing scalability, reimbursement and channel dynamics, and data ecosystem integration. Any quality disruption can quickly translate into safety concerns regulatory exposure and loss of trust, forcing manufacturers to sustain investment in process control and supply resilience. At the same time, intensifying competition and channel shifts toward pharmacy distribution can reshape pricing and margin profiles. On the demand side, interoperability is becoming a defining expectation as monitoring increasingly connects with insulin delivery, automated therapy workflows, and out-of-hospital digital follow-up. Buyers are raising requirements for accuracy consistency and alert performance while relying more on analytics that translate data into actionable guidance. Competition is therefore expanding from hardware specs to a combined play of algorithms ecosystem compatibility and service efficiency.
LP Information, Inc. (LPI) ' newest research report, the ?Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Forecast? looks at past sales and reviews total world Continuous Glucose Monitoring (CGM) System for Diabetes Management sales in 2025, providing a comprehensive analysis by region and market sector of projected Continuous Glucose Monitoring (CGM) System for Diabetes Management sales for 2026 through 2032. With Continuous Glucose Monitoring (CGM) System for Diabetes Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Continuous Glucose Monitoring (CGM) System for Diabetes Management industry.
This Insight Report provides a comprehensive analysis of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Continuous Glucose Monitoring (CGM) System for Diabetes Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Continuous Glucose Monitoring (CGM) System for Diabetes Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Continuous Glucose Monitoring (CGM) System for Diabetes Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Continuous Glucose Monitoring (CGM) System for Diabetes Management.
This report presents a comprehensive overview, market shares, and growth opportunities of Continuous Glucose Monitoring (CGM) System for Diabetes Management market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
A continuous glucose monitoring system is a medical device and data-enabled care solution for diabetes management. It measures glucose levels continuously by placing a disposable sensor in the subcutaneous interstitial space, converting biochemical signals into time-series glucose readings, and presenting trends, rate-of-change insights, and alerts for high and low glucose events. A typical system includes a sensor, a signal transmission module, and a display endpoint such as a dedicated receiver or a mobile application, supported by analytics and reporting functions that facilitate therapy adjustment and follow-up care.
In terms of form factor, the mainstream product is a patch-worn wearable sensor. By usage mode, products commonly fall into real-time systems that automatically present readings and alerts and scan-based systems that require user-initiated checks, with a smaller segment of implantable long-wear options. The core value lies in transforming episodic point testing into continuous visibility of glucose dynamics, enabling earlier risk detection, more informed dosing and lifestyle decisions, and standardized metrics for long-term glycemic evaluation across diverse care settings.
In 2025, annual global shipments of continuous glucose monitoring (CGM) systems for diabetes management were estimated at approximately 1.6?2.4 million units. On an ex-factory basis (a practical proxy for FOB net selling value), the first-year ex-factory value per system typically ranged from around USD 900 to 1,400 per system.
Driven by the rising global diabetes burden and the shift toward more proactive glycemic control, continuous glucose monitoring systems are evolving from niche tools for highly engaged users into foundational infrastructure for broader chronic care. Continuous trend visibility and real-time risk alerts improve day-to-day decision making, increase patient engagement, and provide a scalable data backbone for clinical follow-up and remote care models. As wear comfort improves and wear duration extends, factory calibration and simplified onboarding are lowering adoption barriers. Market expansion is moving beyond type 1 diabetes into insulin-treated type 2 diabetes, and in certain markets further into wider type 2 populations where providers and payers recognize the value of preventing deterioration and acute events.
Challenges Risks and Demand Trends
Key uncertainties center on product reliability and manufacturing scalability, reimbursement and channel dynamics, and data ecosystem integration. Any quality disruption can quickly translate into safety concerns regulatory exposure and loss of trust, forcing manufacturers to sustain investment in process control and supply resilience. At the same time, intensifying competition and channel shifts toward pharmacy distribution can reshape pricing and margin profiles. On the demand side, interoperability is becoming a defining expectation as monitoring increasingly connects with insulin delivery, automated therapy workflows, and out-of-hospital digital follow-up. Buyers are raising requirements for accuracy consistency and alert performance while relying more on analytics that translate data into actionable guidance. Competition is therefore expanding from hardware specs to a combined play of algorithms ecosystem compatibility and service efficiency.
LP Information, Inc. (LPI) ' newest research report, the ?Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Forecast? looks at past sales and reviews total world Continuous Glucose Monitoring (CGM) System for Diabetes Management sales in 2025, providing a comprehensive analysis by region and market sector of projected Continuous Glucose Monitoring (CGM) System for Diabetes Management sales for 2026 through 2032. With Continuous Glucose Monitoring (CGM) System for Diabetes Management sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Continuous Glucose Monitoring (CGM) System for Diabetes Management industry.
This Insight Report provides a comprehensive analysis of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Continuous Glucose Monitoring (CGM) System for Diabetes Management portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Continuous Glucose Monitoring (CGM) System for Diabetes Management market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Continuous Glucose Monitoring (CGM) System for Diabetes Management and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Continuous Glucose Monitoring (CGM) System for Diabetes Management.
This report presents a comprehensive overview, market shares, and growth opportunities of Continuous Glucose Monitoring (CGM) System for Diabetes Management market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Patch Based Wearable Sensor
- Implantable Sensor
- Others
- Intermittently Scanned CGM
- Real Time CGM
- Implantable CGM
- Intensive Insulin Therapy
- Basal Insulin Therapy
- Non Insulin Diabetes Management
- Retail Pharmacy Channel
- DME and Distributor Channel
- Hospital Procurement Channel
- Home and Ambulatory Care
- Outpatient Clinic Follow Up
- Inpatient Glycemic Management
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- DexCom, Inc.
- Medtronic plc
- Senseonics Holdings, Inc.
- Nemaura Medical Inc.
- A. Menarini Diagnostics S.r.l.
- Sinocare Inc.
- Medtrum Technologies Inc.
- MicroTech Medical (Hangzhou) Co., Ltd.
- SiBionics (Shenzhen) Co., Ltd.
- Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
- What is the 10-year outlook for the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
- What factors are driving Continuous Glucose Monitoring (CGM) System for Diabetes Management market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Continuous Glucose Monitoring (CGM) System for Diabetes Management market opportunities vary by end market size?
- How does Continuous Glucose Monitoring (CGM) System for Diabetes Management break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) System for Diabetes Management by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) System for Diabetes Management by Country/Region, 2021, 2025 & 2032
2.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Type
2.2.1 Patch Based Wearable Sensor
2.2.2 Implantable Sensor
2.2.3 Others
2.2.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type
2.2.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
2.2.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Type (2021-2026)
2.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Monitoring Mode
2.3.1 Intermittently Scanned CGM
2.3.2 Real Time CGM
2.3.3 Implantable CGM
2.3.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Monitoring Mode
2.3.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Monitoring Mode (2021-2026)
2.3.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Monitoring Mode (2021-2026)
2.3.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Monitoring Mode (2021-2026)
2.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Patient Therapy Intensity
2.4.1 Intensive Insulin Therapy
2.4.2 Basal Insulin Therapy
2.4.3 Non Insulin Diabetes Management
2.4.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Patient Therapy Intensity
2.4.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Patient Therapy Intensity (2021-2026)
2.4.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Patient Therapy Intensity (2021-2026)
2.4.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Patient Therapy Intensity (2021-2026)
2.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Sales Channel
2.5.1 Retail Pharmacy Channel
2.5.2 DME and Distributor Channel
2.5.3 Hospital Procurement Channel
2.5.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Sales Channel
2.5.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Sales Channel (2021-2026)
2.5.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Sales Channel (2021-2026)
2.5.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Sales Channel (2021-2026)
2.6 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Application
2.6.1 Home and Ambulatory Care
2.6.2 Outpatient Clinic Follow Up
2.6.3 Inpatient Glycemic Management
2.6.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application
2.6.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Market Share by Application (2021-2026)
2.6.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Breakdown Data by Company
3.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales by Company (2021-2026)
3.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Company (2021-2026)
3.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue by Company (2021-2026)
3.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Company (2021-2026)
3.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Company (2021-2026)
3.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Company
3.4 Key Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Location Distribution
3.4.2 Players Continuous Glucose Monitoring (CGM) System for Diabetes Management Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM FOR DIABETES MANAGEMENT BY GEOGRAPHIC REGION
4.1 World Historic Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Geographic Region (2021-2026)
4.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country/Region (2021-2026)
4.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales by Country/Region (2021-2026)
4.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue by Country/Region (2021-2026)
4.3 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
4.4 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
4.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
4.6 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
5 AMERICAS
5.1 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country
5.1.1 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026)
5.1.2 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026)
5.2 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
5.3 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region
6.1.1 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (2021-2026)
6.1.2 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (2021-2026)
6.2 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
6.3 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management by Country
7.1.1 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026)
7.1.2 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026)
7.2 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
7.3 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management by Country
8.1.1 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026)
8.1.2 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026)
8.2 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
8.3 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management
10.3 Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management
10.4 Industry Chain Structure of Continuous Glucose Monitoring (CGM) System for Diabetes Management
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors
11.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Customer
12 WORLD FORECAST REVIEW FOR CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM FOR DIABETES MANAGEMENT BY GEOGRAPHIC REGION
12.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Forecast by Region
12.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Forecast by Region (2027-2032)
12.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Forecast by Type (2027-2032)
12.7 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.1.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 DexCom, Inc.
13.2.1 DexCom, Inc. Company Information
13.2.2 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.2.3 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 DexCom, Inc. Main Business Overview
13.2.5 DexCom, Inc. Latest Developments
13.3 Medtronic plc
13.3.1 Medtronic plc Company Information
13.3.2 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.3.3 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic plc Main Business Overview
13.3.5 Medtronic plc Latest Developments
13.4 Senseonics Holdings, Inc.
13.4.1 Senseonics Holdings, Inc. Company Information
13.4.2 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.4.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Senseonics Holdings, Inc. Main Business Overview
13.4.5 Senseonics Holdings, Inc. Latest Developments
13.5 Nemaura Medical Inc.
13.5.1 Nemaura Medical Inc. Company Information
13.5.2 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.5.3 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Nemaura Medical Inc. Main Business Overview
13.5.5 Nemaura Medical Inc. Latest Developments
13.6 A. Menarini Diagnostics S.r.l.
13.6.1 A. Menarini Diagnostics S.r.l. Company Information
13.6.2 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.6.3 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 A. Menarini Diagnostics S.r.l. Main Business Overview
13.6.5 A. Menarini Diagnostics S.r.l. Latest Developments
13.7 Sinocare Inc.
13.7.1 Sinocare Inc. Company Information
13.7.2 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.7.3 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sinocare Inc. Main Business Overview
13.7.5 Sinocare Inc. Latest Developments
13.8 Medtrum Technologies Inc.
13.8.1 Medtrum Technologies Inc. Company Information
13.8.2 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.8.3 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Medtrum Technologies Inc. Main Business Overview
13.8.5 Medtrum Technologies Inc. Latest Developments
13.9 MicroTech Medical (Hangzhou) Co., Ltd.
13.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information
13.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Main Business Overview
13.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
13.10 SiBionics (Shenzhen) Co., Ltd.
13.10.1 SiBionics (Shenzhen) Co., Ltd. Company Information
13.10.2 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.10.3 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SiBionics (Shenzhen) Co., Ltd. Main Business Overview
13.10.5 SiBionics (Shenzhen) Co., Ltd. Latest Developments
13.11 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
13.11.1 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Company Information
13.11.2 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.11.3 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business Overview
13.11.5 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) System for Diabetes Management by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) System for Diabetes Management by Country/Region, 2021, 2025 & 2032
2.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Type
2.2.1 Patch Based Wearable Sensor
2.2.2 Implantable Sensor
2.2.3 Others
2.2.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type
2.2.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
2.2.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Type (2021-2026)
2.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Monitoring Mode
2.3.1 Intermittently Scanned CGM
2.3.2 Real Time CGM
2.3.3 Implantable CGM
2.3.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Monitoring Mode
2.3.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Monitoring Mode (2021-2026)
2.3.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Monitoring Mode (2021-2026)
2.3.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Monitoring Mode (2021-2026)
2.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Patient Therapy Intensity
2.4.1 Intensive Insulin Therapy
2.4.2 Basal Insulin Therapy
2.4.3 Non Insulin Diabetes Management
2.4.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Patient Therapy Intensity
2.4.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Patient Therapy Intensity (2021-2026)
2.4.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Patient Therapy Intensity (2021-2026)
2.4.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Patient Therapy Intensity (2021-2026)
2.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Sales Channel
2.5.1 Retail Pharmacy Channel
2.5.2 DME and Distributor Channel
2.5.3 Hospital Procurement Channel
2.5.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Sales Channel
2.5.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Sales Channel (2021-2026)
2.5.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Sales Channel (2021-2026)
2.5.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Sales Channel (2021-2026)
2.6 Continuous Glucose Monitoring (CGM) System for Diabetes Management Segment by Application
2.6.1 Home and Ambulatory Care
2.6.2 Outpatient Clinic Follow Up
2.6.3 Inpatient Glycemic Management
2.6.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application
2.6.4.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Market Share by Application (2021-2026)
2.6.4.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Breakdown Data by Company
3.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales by Company (2021-2026)
3.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Company (2021-2026)
3.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue by Company (2021-2026)
3.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Company (2021-2026)
3.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Company (2021-2026)
3.3 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Company
3.4 Key Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Location Distribution
3.4.2 Players Continuous Glucose Monitoring (CGM) System for Diabetes Management Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM FOR DIABETES MANAGEMENT BY GEOGRAPHIC REGION
4.1 World Historic Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Geographic Region (2021-2026)
4.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size by Country/Region (2021-2026)
4.2.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales by Country/Region (2021-2026)
4.2.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue by Country/Region (2021-2026)
4.3 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
4.4 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
4.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
4.6 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth
5 AMERICAS
5.1 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country
5.1.1 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026)
5.1.2 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026)
5.2 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
5.3 Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region
6.1.1 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (2021-2026)
6.1.2 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (2021-2026)
6.2 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
6.3 APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management by Country
7.1.1 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026)
7.1.2 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026)
7.2 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
7.3 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management by Country
8.1.1 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026)
8.1.2 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026)
8.2 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026)
8.3 Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management
10.3 Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management
10.4 Industry Chain Structure of Continuous Glucose Monitoring (CGM) System for Diabetes Management
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors
11.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Customer
12 WORLD FORECAST REVIEW FOR CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM FOR DIABETES MANAGEMENT BY GEOGRAPHIC REGION
12.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Forecast by Region
12.1.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Forecast by Region (2027-2032)
12.1.2 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Forecast by Type (2027-2032)
12.7 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.1.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 DexCom, Inc.
13.2.1 DexCom, Inc. Company Information
13.2.2 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.2.3 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 DexCom, Inc. Main Business Overview
13.2.5 DexCom, Inc. Latest Developments
13.3 Medtronic plc
13.3.1 Medtronic plc Company Information
13.3.2 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.3.3 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic plc Main Business Overview
13.3.5 Medtronic plc Latest Developments
13.4 Senseonics Holdings, Inc.
13.4.1 Senseonics Holdings, Inc. Company Information
13.4.2 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.4.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Senseonics Holdings, Inc. Main Business Overview
13.4.5 Senseonics Holdings, Inc. Latest Developments
13.5 Nemaura Medical Inc.
13.5.1 Nemaura Medical Inc. Company Information
13.5.2 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.5.3 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Nemaura Medical Inc. Main Business Overview
13.5.5 Nemaura Medical Inc. Latest Developments
13.6 A. Menarini Diagnostics S.r.l.
13.6.1 A. Menarini Diagnostics S.r.l. Company Information
13.6.2 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.6.3 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 A. Menarini Diagnostics S.r.l. Main Business Overview
13.6.5 A. Menarini Diagnostics S.r.l. Latest Developments
13.7 Sinocare Inc.
13.7.1 Sinocare Inc. Company Information
13.7.2 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.7.3 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sinocare Inc. Main Business Overview
13.7.5 Sinocare Inc. Latest Developments
13.8 Medtrum Technologies Inc.
13.8.1 Medtrum Technologies Inc. Company Information
13.8.2 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.8.3 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Medtrum Technologies Inc. Main Business Overview
13.8.5 Medtrum Technologies Inc. Latest Developments
13.9 MicroTech Medical (Hangzhou) Co., Ltd.
13.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information
13.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Main Business Overview
13.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
13.10 SiBionics (Shenzhen) Co., Ltd.
13.10.1 SiBionics (Shenzhen) Co., Ltd. Company Information
13.10.2 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.10.3 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SiBionics (Shenzhen) Co., Ltd. Main Business Overview
13.10.5 SiBionics (Shenzhen) Co., Ltd. Latest Developments
13.11 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
13.11.1 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Company Information
13.11.2 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
13.11.3 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business Overview
13.11.5 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Patch Based Wearable Sensor
Table 4. Major Players of Implantable Sensor
Table 5. Major Players of Others
Table 6. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 7. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Table 8. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2021-2026) & ($ million)
Table 9. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2021-2026)
Table 10. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Intermittently Scanned CGM
Table 12. Major Players of Real Time CGM
Table 13. Major Players of Implantable CGM
Table 14. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Monitoring Mode (2021-2026) & (K Units)
Table 15. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Monitoring Mode (2021-2026)
Table 16. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Monitoring Mode (2021-2026) & ($ million)
Table 17. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Monitoring Mode (2021-2026)
Table 18. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Monitoring Mode (2021-2026) & (US$/Unit)
Table 19. Major Players of Intensive Insulin Therapy
Table 20. Major Players of Basal Insulin Therapy
Table 21. Major Players of Non Insulin Diabetes Management
Table 22. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Patient Therapy Intensity (2021-2026) & (K Units)
Table 23. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Patient Therapy Intensity (2021-2026)
Table 24. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Patient Therapy Intensity (2021-2026) & ($ million)
Table 25. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Patient Therapy Intensity (2021-2026)
Table 26. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Patient Therapy Intensity (2021-2026) & (US$/Unit)
Table 27. Major Players of Retail Pharmacy Channel
Table 28. Major Players of DME and Distributor Channel
Table 29. Major Players of Hospital Procurement Channel
Table 30. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Sales Channel (2021-2026) & (K Units)
Table 31. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Sales Channel (2021-2026)
Table 32. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Sales Channel (2021-2026) & ($ million)
Table 33. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Sales Channel (2021-2026)
Table 34. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 35. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale by Application (2021-2026) & (K Units)
Table 36. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Market Share by Application (2021-2026)
Table 37. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2021-2026) & ($ million)
Table 38. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application (2021-2026)
Table 39. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Application (2021-2026) & (US$/Unit)
Table 40. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Company (2021-2026) & (K Units)
Table 41. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Company (2021-2026)
Table 42. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Company (2021-2026) & ($ millions)
Table 43. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Company (2021-2026)
Table 44. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Company (2021-2026) & (US$/Unit)
Table 45. Key Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Producing Area Distribution and Sales Area
Table 46. Players Continuous Glucose Monitoring (CGM) System for Diabetes Management Products Offered
Table 47. Continuous Glucose Monitoring (CGM) System for Diabetes Management Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 48. New Products and Potential Entrants
Table 49. Market M&A Activity & Strategy
Table 50. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Geographic Region (2021-2026) & (K Units)
Table 51. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share Geographic Region (2021-2026)
Table 52. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Geographic Region (2021-2026) & ($ millions)
Table 53. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Geographic Region (2021-2026)
Table 54. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country/Region (2021-2026) & (K Units)
Table 55. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country/Region (2021-2026)
Table 56. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country/Region (2021-2026) & ($ millions)
Table 57. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country/Region (2021-2026)
Table 58. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026) & (K Units)
Table 59. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021-2026)
Table 60. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026) & ($ millions)
Table 61. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 62. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 63. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (2021-2026) & (K Units)
Table 64. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Region (2021-2026)
Table 65. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (2021-2026) & ($ millions)
Table 66. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 67. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 68. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026) & (K Units)
Table 69. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026) & ($ millions)
Table 70. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 71. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026) & (K Units)
Table 73. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021-2026)
Table 74. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 75. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 76. Key Market Drivers & Growth Opportunities of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Table 77. Key Market Challenges & Risks of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Table 78. Key Industry Trends of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Table 79. Continuous Glucose Monitoring (CGM) System for Diabetes Management Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors List
Table 82. Continuous Glucose Monitoring (CGM) System for Diabetes Management Customer List
Table 83. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Region (2027-2032) & (K Units)
Table 84. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Region (2027-2032) & (K Units)
Table 88. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Country (2027-2032) & (K Units)
Table 90. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Country (2027-2032) & (K Units)
Table 92. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Type (2027-2032) & (K Units)
Table 94. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Type (2027-2032) & ($ millions)
Table 95. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Application (2027-2032) & (K Units)
Table 96. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Application (2027-2032) & ($ millions)
Table 97. Abbott Laboratories Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 99. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Abbott Laboratories Main Business
Table 101. Abbott Laboratories Latest Developments
Table 102. DexCom, Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 103. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 104. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. DexCom, Inc. Main Business
Table 106. DexCom, Inc. Latest Developments
Table 107. Medtronic plc Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 108. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 109. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Medtronic plc Main Business
Table 111. Medtronic plc Latest Developments
Table 112. Senseonics Holdings, Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 113. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 114. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Senseonics Holdings, Inc. Main Business
Table 116. Senseonics Holdings, Inc. Latest Developments
Table 117. Nemaura Medical Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 118. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 119. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Nemaura Medical Inc. Main Business
Table 121. Nemaura Medical Inc. Latest Developments
Table 122. A. Menarini Diagnostics S.r.l. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 123. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 124. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. A. Menarini Diagnostics S.r.l. Main Business
Table 126. A. Menarini Diagnostics S.r.l. Latest Developments
Table 127. Sinocare Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 128. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 129. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Sinocare Inc. Main Business
Table 131. Sinocare Inc. Latest Developments
Table 132. Medtrum Technologies Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 133. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 134. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Medtrum Technologies Inc. Main Business
Table 136. Medtrum Technologies Inc. Latest Developments
Table 137. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 138. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 139. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. MicroTech Medical (Hangzhou) Co., Ltd. Main Business
Table 141. MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
Table 142. SiBionics (Shenzhen) Co., Ltd. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 143. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 144. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. SiBionics (Shenzhen) Co., Ltd. Main Business
Table 146. SiBionics (Shenzhen) Co., Ltd. Latest Developments
Table 147. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 149. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business
Table 151. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
Table 1. Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Patch Based Wearable Sensor
Table 4. Major Players of Implantable Sensor
Table 5. Major Players of Others
Table 6. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 7. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Table 8. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Type (2021-2026) & ($ million)
Table 9. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2021-2026)
Table 10. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Intermittently Scanned CGM
Table 12. Major Players of Real Time CGM
Table 13. Major Players of Implantable CGM
Table 14. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Monitoring Mode (2021-2026) & (K Units)
Table 15. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Monitoring Mode (2021-2026)
Table 16. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Monitoring Mode (2021-2026) & ($ million)
Table 17. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Monitoring Mode (2021-2026)
Table 18. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Monitoring Mode (2021-2026) & (US$/Unit)
Table 19. Major Players of Intensive Insulin Therapy
Table 20. Major Players of Basal Insulin Therapy
Table 21. Major Players of Non Insulin Diabetes Management
Table 22. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Patient Therapy Intensity (2021-2026) & (K Units)
Table 23. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Patient Therapy Intensity (2021-2026)
Table 24. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Patient Therapy Intensity (2021-2026) & ($ million)
Table 25. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Patient Therapy Intensity (2021-2026)
Table 26. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Patient Therapy Intensity (2021-2026) & (US$/Unit)
Table 27. Major Players of Retail Pharmacy Channel
Table 28. Major Players of DME and Distributor Channel
Table 29. Major Players of Hospital Procurement Channel
Table 30. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Sales Channel (2021-2026) & (K Units)
Table 31. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Sales Channel (2021-2026)
Table 32. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Sales Channel (2021-2026) & ($ million)
Table 33. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Sales Channel (2021-2026)
Table 34. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Sales Channel (2021-2026) & (US$/Unit)
Table 35. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale by Application (2021-2026) & (K Units)
Table 36. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Market Share by Application (2021-2026)
Table 37. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Application (2021-2026) & ($ million)
Table 38. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application (2021-2026)
Table 39. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Application (2021-2026) & (US$/Unit)
Table 40. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Company (2021-2026) & (K Units)
Table 41. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Company (2021-2026)
Table 42. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Company (2021-2026) & ($ millions)
Table 43. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Company (2021-2026)
Table 44. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Price by Company (2021-2026) & (US$/Unit)
Table 45. Key Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Producing Area Distribution and Sales Area
Table 46. Players Continuous Glucose Monitoring (CGM) System for Diabetes Management Products Offered
Table 47. Continuous Glucose Monitoring (CGM) System for Diabetes Management Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 48. New Products and Potential Entrants
Table 49. Market M&A Activity & Strategy
Table 50. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Geographic Region (2021-2026) & (K Units)
Table 51. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share Geographic Region (2021-2026)
Table 52. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Geographic Region (2021-2026) & ($ millions)
Table 53. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Geographic Region (2021-2026)
Table 54. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country/Region (2021-2026) & (K Units)
Table 55. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country/Region (2021-2026)
Table 56. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country/Region (2021-2026) & ($ millions)
Table 57. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country/Region (2021-2026)
Table 58. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026) & (K Units)
Table 59. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021-2026)
Table 60. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026) & ($ millions)
Table 61. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 62. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 63. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Region (2021-2026) & (K Units)
Table 64. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Region (2021-2026)
Table 65. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Region (2021-2026) & ($ millions)
Table 66. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 67. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 68. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026) & (K Units)
Table 69. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Country (2021-2026) & ($ millions)
Table 70. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 71. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Country (2021-2026) & (K Units)
Table 73. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021-2026)
Table 74. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Type (2021-2026) & (K Units)
Table 75. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Application (2021-2026) & (K Units)
Table 76. Key Market Drivers & Growth Opportunities of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Table 77. Key Market Challenges & Risks of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Table 78. Key Industry Trends of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Table 79. Continuous Glucose Monitoring (CGM) System for Diabetes Management Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Continuous Glucose Monitoring (CGM) System for Diabetes Management Distributors List
Table 82. Continuous Glucose Monitoring (CGM) System for Diabetes Management Customer List
Table 83. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Region (2027-2032) & (K Units)
Table 84. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Region (2027-2032) & (K Units)
Table 88. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Country (2027-2032) & (K Units)
Table 90. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Country (2027-2032) & (K Units)
Table 92. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Type (2027-2032) & (K Units)
Table 94. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Type (2027-2032) & ($ millions)
Table 95. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Forecast by Application (2027-2032) & (K Units)
Table 96. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Forecast by Application (2027-2032) & ($ millions)
Table 97. Abbott Laboratories Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 99. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Abbott Laboratories Main Business
Table 101. Abbott Laboratories Latest Developments
Table 102. DexCom, Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 103. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 104. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. DexCom, Inc. Main Business
Table 106. DexCom, Inc. Latest Developments
Table 107. Medtronic plc Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 108. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 109. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Medtronic plc Main Business
Table 111. Medtronic plc Latest Developments
Table 112. Senseonics Holdings, Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 113. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 114. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Senseonics Holdings, Inc. Main Business
Table 116. Senseonics Holdings, Inc. Latest Developments
Table 117. Nemaura Medical Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 118. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 119. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Nemaura Medical Inc. Main Business
Table 121. Nemaura Medical Inc. Latest Developments
Table 122. A. Menarini Diagnostics S.r.l. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 123. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 124. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. A. Menarini Diagnostics S.r.l. Main Business
Table 126. A. Menarini Diagnostics S.r.l. Latest Developments
Table 127. Sinocare Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 128. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 129. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Sinocare Inc. Main Business
Table 131. Sinocare Inc. Latest Developments
Table 132. Medtrum Technologies Inc. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 133. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 134. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Medtrum Technologies Inc. Main Business
Table 136. Medtrum Technologies Inc. Latest Developments
Table 137. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 138. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 139. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. MicroTech Medical (Hangzhou) Co., Ltd. Main Business
Table 141. MicroTech Medical (Hangzhou) Co., Ltd. Latest Developments
Table 142. SiBionics (Shenzhen) Co., Ltd. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 143. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 144. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. SiBionics (Shenzhen) Co., Ltd. Main Business
Table 146. SiBionics (Shenzhen) Co., Ltd. Latest Developments
Table 147. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Basic Information, Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product Portfolios and Specifications
Table 149. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Main Business
Table 151. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Figure 2. Continuous Glucose Monitoring (CGM) System for Diabetes Management Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country/Region (2025)
Figure 10. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Patch Based Wearable Sensor
Figure 12. Product Picture of Implantable Sensor
Figure 13. Product Picture of Others
Figure 14. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type in 2026
Figure 15. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Intermittently Scanned CGM
Figure 17. Product Picture of Real Time CGM
Figure 18. Product Picture of Implantable CGM
Figure 19. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Monitoring Mode in 2026
Figure 20. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Monitoring Mode (2021-2026)
Figure 21. Product Picture of Intensive Insulin Therapy
Figure 22. Product Picture of Basal Insulin Therapy
Figure 23. Product Picture of Non Insulin Diabetes Management
Figure 24. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Patient Therapy Intensity in 2026
Figure 25. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Patient Therapy Intensity (2021-2026)
Figure 26. Product Picture of Retail Pharmacy Channel
Figure 27. Product Picture of DME and Distributor Channel
Figure 28. Product Picture of Hospital Procurement Channel
Figure 29. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Sales Channel in 2026
Figure 30. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Sales Channel (2021-2026)
Figure 31. Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumed in Home and Ambulatory Care
Figure 32. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Home and Ambulatory Care (2021-2026) & (K Units)
Figure 33. Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumed in Outpatient Clinic Follow Up
Figure 34. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Outpatient Clinic Follow Up (2021-2026) & (K Units)
Figure 35. Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumed in Inpatient Glycemic Management
Figure 36. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Inpatient Glycemic Management (2021-2026) & (K Units)
Figure 37. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Market Share by Application (2025)
Figure 38. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application in 2026
Figure 39. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Company in 2026 (K Units)
Figure 40. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Company in 2026
Figure 41. Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Company in 2026 ($ millions)
Figure 42. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Company in 2026
Figure 43. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Geographic Region in 2026
Figure 45. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 46. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 47. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 48. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 49. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 50. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 52. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 53. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country in 2026
Figure 54. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021-2026)
Figure 55. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 56. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 57. United States Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Region in 2026
Figure 62. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Region (2021-2026)
Figure 63. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 64. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 65. China Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 69. India Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country in 2026
Figure 73. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021-2026)
Figure 74. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 75. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 76. Germany Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 77. France Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 84. Egypt Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management in 2026
Figure 90. Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Figure 91. Industry Chain Structure of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Figure 92. Channels of Distribution
Figure 93. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Forecast by Region (2027-2032)
Figure 94. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Figure 2. Continuous Glucose Monitoring (CGM) System for Diabetes Management Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country/Region (2025)
Figure 10. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Patch Based Wearable Sensor
Figure 12. Product Picture of Implantable Sensor
Figure 13. Product Picture of Others
Figure 14. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type in 2026
Figure 15. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Intermittently Scanned CGM
Figure 17. Product Picture of Real Time CGM
Figure 18. Product Picture of Implantable CGM
Figure 19. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Monitoring Mode in 2026
Figure 20. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Monitoring Mode (2021-2026)
Figure 21. Product Picture of Intensive Insulin Therapy
Figure 22. Product Picture of Basal Insulin Therapy
Figure 23. Product Picture of Non Insulin Diabetes Management
Figure 24. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Patient Therapy Intensity in 2026
Figure 25. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Patient Therapy Intensity (2021-2026)
Figure 26. Product Picture of Retail Pharmacy Channel
Figure 27. Product Picture of DME and Distributor Channel
Figure 28. Product Picture of Hospital Procurement Channel
Figure 29. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Sales Channel in 2026
Figure 30. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Sales Channel (2021-2026)
Figure 31. Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumed in Home and Ambulatory Care
Figure 32. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Home and Ambulatory Care (2021-2026) & (K Units)
Figure 33. Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumed in Outpatient Clinic Follow Up
Figure 34. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Outpatient Clinic Follow Up (2021-2026) & (K Units)
Figure 35. Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumed in Inpatient Glycemic Management
Figure 36. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Inpatient Glycemic Management (2021-2026) & (K Units)
Figure 37. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sale Market Share by Application (2025)
Figure 38. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Application in 2026
Figure 39. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales by Company in 2026 (K Units)
Figure 40. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Company in 2026
Figure 41. Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue by Company in 2026 ($ millions)
Figure 42. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Company in 2026
Figure 43. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Geographic Region in 2026
Figure 45. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 46. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 47. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 48. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 49. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 50. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales 2021-2026 (K Units)
Figure 52. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue 2021-2026 ($ millions)
Figure 53. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country in 2026
Figure 54. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021-2026)
Figure 55. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 56. Americas Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 57. United States Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Region in 2026
Figure 62. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Region (2021-2026)
Figure 63. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 64. APAC Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 65. China Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 69. India Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country in 2026
Figure 73. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share by Country (2021-2026)
Figure 74. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 75. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 76. Germany Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 77. France Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share by Application (2021-2026)
Figure 84. Egypt Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management in 2026
Figure 90. Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Figure 91. Industry Chain Structure of Continuous Glucose Monitoring (CGM) System for Diabetes Management
Figure 92. Channels of Distribution
Figure 93. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Forecast by Region (2027-2032)
Figure 94. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Revenue Market Share Forecast by Application (2027-2032)
